Indian pharma industry to witness 8-10% revenue growth in fiscal 2024: CRISIL
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
The generous donation includes multiple medical equipments
This exposé embarks on an illuminative journey, unfurling the crucial stratagems imperative for upholding public health, achieved through the unyielding fortress of pharmaceutical quality safeguards
India will account for about 18% of the Asia-Pacific (APAC) MRI systems market in 2023
LyondellBasell is among the top three global polyolefin manufacturers in terms of capacity and sustainable solutions
Qualifyze specializes in Good Practice audits (GxP) audits and covers a wide range of areas, including excipients, starting materials, packaging, sustainability
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
Unfortunate to see PM’s ‘Make in India’ dream being bulldozed
CMOs showed an increasing reluctance to take on debt in 2022
Subscribe To Our Newsletter & Stay Updated